Clinical study of mahatiktak ghruta and tranexamic acid in dysfunctional uterine bleeding
Phase 3
- Conditions
- Health Condition 1: N80-N98- Noninflammatory disorders of female genital tract
- Registration Number
- CTRI/2024/01/061305
- Lead Sponsor
- Dr Archana Singh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Any women having age group between 18-45 years complaints of asrygdar.
2.Patients who willing to give consent for this study.
Exclusion Criteria
1. Known case of breast abscess, mastitis, cracked nipples and breast cancer.
2.Pregnancy,lactation,known case of fibroid,adenomyosis,endometriosis.
3. Patients suffering from asrugdar due to secondary cause like HIV, TB.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.To determine the clinical effectiveness of mahatiktak ghruta and tranexamic acid in the management of asrugdar w.s.r to dysfunctional uterine bleeding. <br/ ><br>2. To comapare the effectiveness of mahatiktak ghruta and tranexamic acid in the management of asrugdar w.s.r to dysfunctional uterine bleedingTimepoint: At Baseline, 1st week,2nd week and 3 months
- Secondary Outcome Measures
Name Time Method ilTimepoint: Nil